| 000 | 01415 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517134530.0 | ||
| 264 | 0 | _c20180427 | |
| 008 | 201804s 0 0 eng d | ||
| 022 | _a1098-2825 | ||
| 024 | 7 |
_a10.1002/jcla.22138 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhao, Shengchun | |
| 245 | 0 | 0 |
_aThe association of NLRP3 and TNFRSF1A polymorphisms with risk of ankylosing spondylitis and treatment efficacy of etanercept. _h[electronic resource] |
| 260 |
_bJournal of clinical laboratory analysis _cNov 2017 |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aEtanercept _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aLinkage Disequilibrium |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNLR Family, Pyrin Domain-Containing 3 Protein _xgenetics |
| 650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor, Type I _xgenetics |
| 650 | 0 | 4 |
_aSpondylitis, Ankylosing _xdrug therapy |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aChen, Hongwei | |
| 700 | 1 | _aWu, Guolin | |
| 700 | 1 | _aZhao, Chen | |
| 773 | 0 |
_tJournal of clinical laboratory analysis _gvol. 31 _gno. 6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jcla.22138 _zAvailable from publisher's website |
| 999 |
_c26812620 _d26812620 |
||